Skip to main content

Table 1 Clinical characteristics of TCGA and GEO dataset

From: Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinoma

Variable TCGA-LUAD dataset (N = 477) N(%) GEO LUAD dataset (N = 318)
GSE30219 N(%) GSE37745 N(%) GSE50081 N(%)
Age
  < 68 261 (54.7) 61 (73.5) 71 (67.0) 48 (37.2)
  ≥68 216 (45.3) 22 (26.5) 35 (33.0) 81 (62.8)
Gender     
 Female 257 (53.9) 18 (21.7) 60 (56.6) 62 (48.1)
 Male 220 (46.1) 65 (78.3) 46 (43.4) 67 (51.9)
Stage
 I 4 (0.8) NA NA NA
 IA 124 (26.0) NA NA 37 (28.7)
 IB 125 (26.2) NA NA 56 (43.4)
 II 191 (40.0) NA NA NA
 IIA     7 (5.4)
 IIB     29 (22.5)
 III NA NA NA 0 (0)
 IV 25 (5.2) NA NA 0 (0)
 Unknow 8 (1.7) NA NA 0 (0)
T
 T1 159 (33.3) 69 (83.1) NA 44 (34.1)
 T2 254 (53.2) 12 (14.5) NA 83 (64.3)
 T3 43 (9.0) 2 (2.4) NA 2 (1.6)
 T4 18 (3.8) 0 (0) NA 0 (0)
 TX 3 (0.6) 0 (0) NA 0 (0)
N
 N0 307 (64.4) 80 (96.4) NA 95 (73.6)
 N1 90 (18.9) 3 (3.6) NA 34 (26.4)
 N2 67 (14.0) 0 (0) NA 0 (0)
 NX 2 (0.4) 0 (0) NA 0 (0)
 Unknow 1 (0.2) 0 (0) NA 0 (0)
M
 M0 313 (65.6) 83 (100) NA 129 (100)
 M1 24 (5.0) 0 (0) NA 0 (0)
 MX 136 (28.5) 0 (0) NA 0 (0)